Skip to content
WorldBrand.AI

Ridgeback Biotherapeutics controversies

Controversies tied to this brand in public sources. A listing is not a finding of fault.

Back to profile1 entries

  1. 2020

    Ridgeback cited in a COVID-19 funding whistleblower complaint

    Rick Bright, a former director of the Biomedical Advanced Research and Development Authority, filed a whistleblower complaint that mentioned Ridgeback and alleged the company lobbied the government for millions of dollars to assist molnupiravir development. The available reference does not establish a final finding of wrongdoing or the ultimate disposition of the allegation.

    Source